Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System

Objective

The aim of this study is to assess a device called the TEG 6s System in determining if there is a DOAC (Direct Oral Anti-Coagulant Drug) in the subject’s system and what type of DOAC it is.

Location:

Essentia Health Duluth

Disclosures:

None

For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.

Last Updated: 08/29/2016

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Clinical Trials at 866-839-4128
or clinicaltrials@eirh.org